Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 13 | 2023 | 1774 | 3.400 |
Why?
|
Postmenopause | 8 | 2023 | 2440 | 2.110 |
Why?
|
Sleep | 15 | 2023 | 4406 | 1.810 |
Why?
|
Ovarian Neoplasms | 10 | 2021 | 4754 | 1.480 |
Why?
|
Ovulation | 2 | 2020 | 191 | 1.420 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 487 | 1.310 |
Why?
|
Adiposity | 5 | 2019 | 1785 | 1.190 |
Why?
|
Hyperglycemia | 3 | 2022 | 1338 | 1.050 |
Why?
|
Parity | 2 | 2019 | 920 | 1.030 |
Why?
|
Spinal Fractures | 2 | 2022 | 679 | 1.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2021 | 957 | 0.960 |
Why?
|
Premenopause | 2 | 2020 | 1026 | 0.960 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 11413 | 0.950 |
Why?
|
Hip Fractures | 2 | 2022 | 919 | 0.910 |
Why?
|
Atherosclerosis | 7 | 2023 | 3267 | 0.890 |
Why?
|
Receptors, Leptin | 4 | 2019 | 356 | 0.850 |
Why?
|
Circadian Rhythm | 4 | 2023 | 2575 | 0.830 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 12 | 0.780 |
Why?
|
Nurses | 5 | 2023 | 2447 | 0.760 |
Why?
|
Actigraphy | 4 | 2021 | 454 | 0.760 |
Why?
|
Phthalic Acids | 5 | 2016 | 414 | 0.740 |
Why?
|
Dehydroepiandrosterone | 2 | 2019 | 254 | 0.740 |
Why?
|
Prospective Studies | 30 | 2023 | 51869 | 0.710 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2001 | 0.700 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 257 | 0.670 |
Why?
|
Diet, Vegetarian | 1 | 2019 | 172 | 0.620 |
Why?
|
Menopause | 4 | 2023 | 1605 | 0.610 |
Why?
|
Body Mass Index | 14 | 2022 | 12523 | 0.600 |
Why?
|
Contraceptives, Oral | 1 | 2019 | 562 | 0.600 |
Why?
|
Adipokines | 2 | 2016 | 314 | 0.600 |
Why?
|
Risk Factors | 34 | 2023 | 71009 | 0.580 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2016 | 202 | 0.540 |
Why?
|
Amino Acids | 2 | 2022 | 1724 | 0.530 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 24031 | 0.530 |
Why?
|
Obesity | 8 | 2023 | 12419 | 0.520 |
Why?
|
Ovary | 1 | 2019 | 997 | 0.520 |
Why?
|
Self Report | 4 | 2023 | 3407 | 0.520 |
Why?
|
Diet | 5 | 2022 | 7797 | 0.510 |
Why?
|
Female | 62 | 2023 | 375449 | 0.490 |
Why?
|
C-Reactive Protein | 3 | 2021 | 3689 | 0.490 |
Why?
|
Follow-Up Studies | 15 | 2022 | 38748 | 0.480 |
Why?
|
Depression | 7 | 2022 | 7454 | 0.480 |
Why?
|
Child Abuse | 1 | 2022 | 996 | 0.470 |
Why?
|
Environmental Pollutants | 4 | 2016 | 1138 | 0.460 |
Why?
|
Pregnancy in Diabetics | 1 | 2014 | 181 | 0.460 |
Why?
|
Hydrocortisone | 2 | 2019 | 1797 | 0.450 |
Why?
|
Middle Aged | 42 | 2023 | 212292 | 0.450 |
Why?
|
Postpartum Period | 3 | 2017 | 1012 | 0.450 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2824 | 0.450 |
Why?
|
Blood Glucose | 6 | 2022 | 6217 | 0.440 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 345 | 0.440 |
Why?
|
Metabolic Diseases | 1 | 2019 | 654 | 0.440 |
Why?
|
Longevity | 1 | 2020 | 1079 | 0.430 |
Why?
|
Leptin | 5 | 2023 | 1597 | 0.430 |
Why?
|
Hypertension | 4 | 2021 | 8262 | 0.430 |
Why?
|
Coronary Disease | 4 | 2022 | 6083 | 0.410 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 376 | 0.400 |
Why?
|
Inflammation | 6 | 2023 | 10335 | 0.400 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1888 | 0.400 |
Why?
|
Humans | 74 | 2023 | 725187 | 0.390 |
Why?
|
Endocrine Disruptors | 1 | 2014 | 232 | 0.390 |
Why?
|
Adiponectin | 5 | 2023 | 1087 | 0.380 |
Why?
|
Adult | 35 | 2023 | 211615 | 0.370 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 14701 | 0.360 |
Why?
|
Insulin | 7 | 2022 | 6562 | 0.350 |
Why?
|
Sex Factors | 3 | 2019 | 10382 | 0.350 |
Why?
|
Incidence | 8 | 2022 | 20750 | 0.350 |
Why?
|
Insulin Resistance | 1 | 2022 | 3871 | 0.330 |
Why?
|
Life Style | 5 | 2023 | 3780 | 0.310 |
Why?
|
Adipose Tissue | 2 | 2016 | 3264 | 0.300 |
Why?
|
Age Factors | 3 | 2020 | 18339 | 0.300 |
Why?
|
Time Factors | 8 | 2021 | 40186 | 0.290 |
Why?
|
Aged | 24 | 2023 | 161486 | 0.280 |
Why?
|
Sleep Deprivation | 3 | 2023 | 815 | 0.280 |
Why?
|
Saliva | 3 | 2019 | 820 | 0.270 |
Why?
|
Motor Activity | 1 | 2015 | 2712 | 0.260 |
Why?
|
Stress, Psychological | 2 | 2022 | 4160 | 0.260 |
Why?
|
Health Surveys | 4 | 2020 | 4001 | 0.260 |
Why?
|
Overweight | 2 | 2017 | 2285 | 0.250 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2019 | 685 | 0.250 |
Why?
|
United States | 15 | 2023 | 68403 | 0.240 |
Why?
|
Feeding Behavior | 1 | 2016 | 3166 | 0.230 |
Why?
|
Polysomnography | 4 | 2023 | 1744 | 0.220 |
Why?
|
Noise, Transportation | 1 | 2023 | 55 | 0.220 |
Why?
|
Longitudinal Studies | 6 | 2022 | 13698 | 0.220 |
Why?
|
Metabolomics | 2 | 2021 | 1421 | 0.210 |
Why?
|
Aging | 2 | 2021 | 8530 | 0.210 |
Why?
|
Fasting | 2 | 2019 | 1587 | 0.200 |
Why?
|
Snoring | 1 | 2022 | 176 | 0.200 |
Why?
|
Lipids | 3 | 2022 | 3298 | 0.190 |
Why?
|
Ownership | 1 | 2022 | 325 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8452 | 0.190 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3296 | 0.190 |
Why?
|
C-Peptide | 2 | 2018 | 405 | 0.180 |
Why?
|
Comorbidity | 3 | 2020 | 10247 | 0.180 |
Why?
|
Basal Metabolism | 1 | 2020 | 168 | 0.170 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12329 | 0.170 |
Why?
|
Prevalence | 4 | 2019 | 14992 | 0.170 |
Why?
|
Calcium Channel Blockers | 1 | 2021 | 684 | 0.160 |
Why?
|
Interleukin-6 | 2 | 2019 | 3150 | 0.160 |
Why?
|
Nails | 1 | 2019 | 287 | 0.150 |
Why?
|
Health Occupations | 1 | 2018 | 219 | 0.150 |
Why?
|
Male | 21 | 2023 | 347096 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 675 | 0.150 |
Why?
|
Maternal Age | 1 | 2019 | 799 | 0.140 |
Why?
|
Prolactin | 1 | 2018 | 666 | 0.140 |
Why?
|
Gastroesophageal Reflux | 1 | 2023 | 743 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 258 | 0.140 |
Why?
|
Odds Ratio | 3 | 2019 | 9839 | 0.140 |
Why?
|
Hyperhomocysteinemia | 1 | 2016 | 126 | 0.140 |
Why?
|
Nutrition Surveys | 4 | 2017 | 1603 | 0.140 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2016 | 92 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1214 | 0.140 |
Why?
|
Ovariectomy | 1 | 2018 | 662 | 0.140 |
Why?
|
Hair | 1 | 2019 | 488 | 0.140 |
Why?
|
Sleep, REM | 1 | 2019 | 583 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 975 | 0.130 |
Why?
|
Pregnancy Trimesters | 1 | 2016 | 190 | 0.130 |
Why?
|
Flavones | 1 | 2014 | 64 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1479 | 0.130 |
Why?
|
Flavanones | 1 | 2014 | 72 | 0.130 |
Why?
|
Anthocyanins | 1 | 2014 | 74 | 0.130 |
Why?
|
Risk | 3 | 2017 | 9700 | 0.120 |
Why?
|
Flavonols | 1 | 2014 | 85 | 0.120 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 536 | 0.120 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4072 | 0.120 |
Why?
|
Politics | 1 | 2020 | 768 | 0.120 |
Why?
|
Spine | 1 | 2020 | 1108 | 0.120 |
Why?
|
Insulin Infusion Systems | 1 | 2014 | 206 | 0.110 |
Why?
|
Feces | 1 | 2019 | 1366 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1357 | 0.110 |
Why?
|
Mexican Americans | 1 | 2014 | 165 | 0.110 |
Why?
|
Folic Acid | 2 | 2016 | 1289 | 0.110 |
Why?
|
Exercise | 2 | 2022 | 5487 | 0.110 |
Why?
|
Adolescent | 6 | 2022 | 84401 | 0.110 |
Why?
|
Environmental Exposure | 3 | 2023 | 4182 | 0.110 |
Why?
|
Pregnancy Trimester, First | 1 | 2016 | 836 | 0.110 |
Why?
|
Pregnancy | 5 | 2017 | 28145 | 0.110 |
Why?
|
Glucose Intolerance | 1 | 2016 | 583 | 0.110 |
Why?
|
Hysterectomy | 1 | 2018 | 916 | 0.110 |
Why?
|
Neoplasms | 1 | 2021 | 20941 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 1143 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2019 | 2761 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5937 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2018 | 1204 | 0.100 |
Why?
|
Physical Fitness | 1 | 2016 | 730 | 0.100 |
Why?
|
Flavonoids | 1 | 2014 | 449 | 0.100 |
Why?
|
Sleep Apnea Syndromes | 1 | 2019 | 916 | 0.100 |
Why?
|
Body Weight | 2 | 2019 | 4657 | 0.100 |
Why?
|
Wakefulness | 1 | 2017 | 1231 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5522 | 0.090 |
Why?
|
Environmental Monitoring | 2 | 2014 | 1401 | 0.090 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 671 | 0.090 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1140 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2022 | 74206 | 0.090 |
Why?
|
Brain | 1 | 2016 | 25764 | 0.090 |
Why?
|
Young Adult | 8 | 2022 | 55781 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4079 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2103 | 0.080 |
Why?
|
Reference Values | 1 | 2016 | 4999 | 0.080 |
Why?
|
Child | 4 | 2022 | 75163 | 0.080 |
Why?
|
Boston | 3 | 2016 | 9288 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12249 | 0.080 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2023 | 547 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2318 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19624 | 0.070 |
Why?
|
Diabetes, Gestational | 1 | 2016 | 1135 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 28737 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2238 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13358 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2974 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2022 | 4305 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2651 | 0.070 |
Why?
|
Registries | 1 | 2019 | 7898 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2023 | 1797 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2015 | 2750 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57656 | 0.060 |
Why?
|
Weight Loss | 1 | 2014 | 2521 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 5930 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6197 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2022 | 112 | 0.060 |
Why?
|
Aircraft | 1 | 2023 | 114 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2769 | 0.050 |
Why?
|
Stroke | 2 | 2022 | 9579 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2022 | 202 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21591 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 275 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8475 | 0.050 |
Why?
|
Albumins | 1 | 2022 | 564 | 0.050 |
Why?
|
Tomography | 1 | 2021 | 376 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 40440 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 703 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13157 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 868 | 0.040 |
Why?
|
Horses | 1 | 2019 | 303 | 0.040 |
Why?
|
Work Schedule Tolerance | 1 | 2022 | 562 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 789 | 0.040 |
Why?
|
Hemoglobins | 1 | 2022 | 1518 | 0.040 |
Why?
|
Metabolome | 1 | 2023 | 855 | 0.040 |
Why?
|
Diethylhexyl Phthalate | 1 | 2016 | 79 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2019 | 721 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15019 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 2013 | 0.030 |
Why?
|
Meat | 1 | 2019 | 597 | 0.030 |
Why?
|
Immunoassay | 1 | 2018 | 751 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 425 | 0.030 |
Why?
|
Leisure Activities | 1 | 2016 | 304 | 0.030 |
Why?
|
Animals | 3 | 2022 | 168714 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23185 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2016 | 720 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2017 | 414 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2022 | 11968 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23448 | 0.030 |
Why?
|
Tea | 1 | 2014 | 273 | 0.030 |
Why?
|
Testosterone | 1 | 2023 | 2386 | 0.030 |
Why?
|
Mothers | 1 | 2022 | 2085 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1589 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2597 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3479 | 0.030 |
Why?
|
Pregnant Women | 1 | 2016 | 543 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17354 | 0.020 |
Why?
|
Prenatal Care | 1 | 2017 | 1070 | 0.020 |
Why?
|
China | 1 | 2016 | 2199 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5758 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2443 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2016 | 935 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 2021 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2519 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6432 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7022 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6398 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 39918 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 3983 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8556 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2016 | 3225 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 7851 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9801 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9588 | 0.010 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(96)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_